These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9487504)

  • 1. New European clinical trial regulations are "unacceptable" to industry.
    Davidson S
    Nat Biotechnol; 1998 Feb; 16(2):127. PubMed ID: 9487504
    [No Abstract]   [Full Text] [Related]  

  • 2. European drug industry concerned over proposed clinical-trial legislation.
    Rogers A
    Lancet; 1997 Nov; 350(9091):1609. PubMed ID: 11655209
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethicists bemoan shortened clinical trial approval time.
    Dove A
    Nat Med; 1999 Dec; 5(12):1336. PubMed ID: 10581055
    [No Abstract]   [Full Text] [Related]  

  • 4. Proposal for a good clinical practice directive.
    European Commission
    Bull Med Ethics; 1998 Feb; No. 135():6-11. PubMed ID: 11657249
    [No Abstract]   [Full Text] [Related]  

  • 5. Federal regulation of REB review of clinical trials: a modest but easy step towards an accountable REB review structure in Canada.
    Lemmens T
    Health Law Rev; 2005; 13(2-3):39-50. PubMed ID: 16459413
    [No Abstract]   [Full Text] [Related]  

  • 6. European directive on clinical trials.
    Bull Med Ethics; 1999 May; No. 148():3-4. PubMed ID: 11657983
    [No Abstract]   [Full Text] [Related]  

  • 7. Institutional review boards and clinical trials registry.
    Maloney DM
    Hum Res Rep; 2004 Nov; 19(11):3. PubMed ID: 15675087
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in gene therapy regulation.
    Lecomte V; Taylor A
    Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials committees: how long is the protocol review and approval process in Spain? A prospective study.
    Ortega R; Dal-RĂ© R
    IRB; 1995; 17(4):6-9. PubMed ID: 11654218
    [No Abstract]   [Full Text] [Related]  

  • 10. Harmonization in the regulation of pharmaceutical research and human rights: the need to think globally.
    Dominguez-Urban I
    Cornell Int Law J; 1997; 30(2):245-86. PubMed ID: 12194190
    [No Abstract]   [Full Text] [Related]  

  • 11. International research agreement leads to new U.S. guidelines.
    Maloney DM
    Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
    [No Abstract]   [Full Text] [Related]  

  • 12. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use.
    Int Dig Health Legis; 1997; 48(2):231-4. PubMed ID: 11656783
    [No Abstract]   [Full Text] [Related]  

  • 13. Institutional review boards (IRBs) would have an increased role in international research.
    Maloney DM
    Hum Res Rep; 2002 Oct; 17(10):9. PubMed ID: 12731498
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 15. American IRBs and Dutch research ethics committees: how they compare.
    Bergkamp L
    IRB; 1988; 10(5):1-6. PubMed ID: 11650072
    [No Abstract]   [Full Text] [Related]  

  • 16. Registration of clinical trials--voluntary or mandatory?
    Steinbrook R
    N Engl J Med; 2004 Oct; 351(18):1820-2. PubMed ID: 15509812
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium on the Law of 20 December 1988 Concerning Biomedical Research on Human Subjects: Protection Committee or Ethics Committee?
    J Int Bioethique; 1993 Mar; 4(Special Issue):61-4. PubMed ID: 11652137
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 19. New federal guidance adds duties for institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2005 Nov; 20(11):1-2. PubMed ID: 16358479
    [No Abstract]   [Full Text] [Related]  

  • 20. Responses to the Gagnon report and REBs.
    Gagnon D;
    NCBHR Commun; 1993; 4(2):3-5. PubMed ID: 11652886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.